Patent 7842705 was granted and assigned to Emory University on November, 2010 by the United States Patent and Trademark Office.
The present invention is directed to curcumin analogs exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.